&w=3840&q=100)
Centre approves ₹33,081 crore to states for health infra upgrade by 2026
Launched in 2021, PM-ABHIM is a centrally sponsored scheme (CSS) with some components funded directly by the Centre. The total financial outlay of the scheme is ₹64,180 crore. It aims to prepare India's health system to better handle current and future pandemics and disasters by enhancing public health infrastructure.
What the scheme covers
Under the CSS portion of the scheme, support is being provided to States and UTs to undertake five key activities:
-Construction of 17,788 Ayushman Arogya Mandirs (AAMs): These are sub-centres without buildings that are now being upgraded as Health and Wellness Centres under the Ayushman Bharat initiative.
-Setting up 11,024 Urban Ayushman Arogya Mandirs (U-AAMs): These centres will primarily serve people in slums and similar urban areas.
-Creation of 3,382 Block Public Health Units (BPHUs)
-Establishment of 730 Integrated Public Health Labs (IPHLs)
-Setting up 602 critical care hospital blocks: These specialised blocks will come up in districts with a population of more than 500,000 to provide advanced care services.
Progress on infra development so far
Out of the total scheme period allocation, ₹33,081.82 crore has already been approved for strengthening infrastructure in states and UTs. This covers:
-10,609 building-less Ayushman Arogya Mandirs (AAMs)
-5,456 urban Ayushman Arogya Mandirs (U-AAMs)
-2,151 block public health units
-744 integrated public health labs
-621 critical care hospital blocks
These projects have been cleared for funding across financial years from 2021–22 to 2025–26.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Pharma firms get one-month extension to submit declarations under UCPMP
The Centre has extended the deadline for pharma company heads to submit their legal self-declarations under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP). The declaration assures the government that companies will not engage in unethical marketing practices to promote their drugs. In a circular dated July 31, the Department of Pharmaceuticals (DoP) granted pharma associations a one-month extension until August 31 to file the self-declaration undertaking. This undertaking must be signed by the executive head of the company, assuring compliance with the marketing practices code. The signatory could be the Managing Director or the Chief Executive Officer (CEO) of the company. Previously, these declarations were required to be submitted within two months after the end of every financial year, i.e., by June 30. The deadline was first extended to July 31 after some firms requested more time, citing difficulties in meeting the deadline. The deadline has now been further extended to August 31. The extension comes as a relief for these companies, as failure to meet the requirements would have led to government action. The circular, reviewed by Business Standard, also instructed pharma companies to disclose their marketing expenditure according to UCPMP rules. The UCPMP, launched in March 2024, aims to bring transparency and ensure ethical conduct by pharmaceutical companies in their marketing practices. The code prohibits firms from offering gifts, travel, hospitality, or monetary benefits to doctors in exchange for prescribing specific medicines. While the code also bars pharma firms from providing free drug samples to individuals who are not qualified to prescribe them, it also regulates events, seminars, and workshops involving the pharmaceutical industry and doctors.
United News of India
5 hours ago
- United News of India
Over 23.8L calls received on Tele-MANAS helpline since its launch: Govt
New Delhi, Aug 1 (UNI) In almost last three years since its launch, the National Tele Mental Health Programme has received over 23.82 lakh calls through the Tele-MANAS helpline, which operates from 53 centres across 36 States and Union Territories to provide counselling and care services via telecommunication, the Ministry of Health and Family Welfare informed the Lok Sabha today. The National Mental Health Programme (NMHP) is implemented across the country with the District Mental Health Programme (DMHP) component sanctioned in 767 districts. Under DMHP, States and UTs receive support through the National Health Mission to provide outpatient services, counselling, psycho-social interventions, continuing care, outreach, ambulance services, and drugs at Community Health Centres (CHCs) and Primary Health Centres (PHCs). District hospitals also offer 10-bedded inpatient facilities, said Union Minister of State for Health and Family Welfare, Prataprao Jadhav, said in a written reply in the Lower House. Moreover, more than 1.77 lakh Sub Health Centres and Primary Health Centres have been upgraded to Ayushman Arogya Mandirs, where mental health services are now integrated into comprehensive primary care packages, supported by operational guidelines and training manuals on mental, neurological, and substance use disorders, he added. At the tertiary care level, 25 Centres of Excellence have been sanctioned to enhance postgraduate education in mental health and provide advanced treatment. Additionally, 19 government medical colleges have been supported to strengthen 47 postgraduate departments specializing in mental health. To expand the workforce, 69 institutions are approved to conduct clinical psychology courses and 9 for rehabilitation psychology by the Rehabilitation Council of India. New courses, including and M.A. in Clinical Psychology, were launched in the 2024-25 academic year. The Government is also enhancing manpower in underserved areas through online training for healthcare and paramedical professionals via Digital Academies, said the Minister. UNI AJ GNK 1838
Hans India
13 hours ago
- Hans India
Lumpy Skin Disease reported in 10 states, over 28 cr animals vaccinated: Centre
New Delhi: Lumpy Skin Disease (LSD) has been reported in cattle from 10 states in the country in 2025, the Centre informed the Parliament. LSD is a transboundary animal disease that has gained significant attention in India due to its severe impact on cattle health and the dairy industry. The disease is characterised by the development of skin nodules across the body, fever, swollen lymph nodes, decreased milk yield, and difficulty in movement. In a written reply to the Rajya Sabha, Union Minister of State for Fisheries, Animal Husbandry and Dairying, Prof. S.P. Singh Baghel, said that till July 24, 'LSD has been reported in 10 states namely Andhra Pradesh, Kerala, Tamil Nadu, Telangana, Gujarat, Madhya Pradesh, Assam, Mizoram, Maharashtra and Karnataka'. 'Presently active cases are reported only in Maharashtra,' he added. Gujarat is also seeing a resurgence in LSD cases, infecting 300 cattle across eight districts in the state. 'More than 28 crore animals have also been vaccinated against LSD since 2022,' Baghel said. The Minister noted that vaccination among cattle was highest in Uttar Pradesh (4.6 crore), followed by Maharashtra (4.13 crore) and Madhya Pradesh (3 crore). LSD virus transmission is primarily attributed to vector bites, with mosquitoes, ticks, and other biting insects playing a crucial role. In the last two years, about 200,000 cattle have died across the nation, while millions more have lost their milk production capabilities due to LSD. Notably, financial assistance is provided to states according to their demand for procuring vaccine doses for vaccination against LSD and related disease control activities under the Assistance to States for Control of Animal Diseases (ASCAD) of the Livestock Health and Disease Control Programme (LHDCP). 'The funds of Rs. 196.61 crore have been released to states/UTs during the year 2024-25,' Baghel said.
